暴发性与急性非暴发性心肌炎伴左室收缩功能障碍的预后比较
本研究为国际多中心回顾性注册研究,纳入220例经组织学证实的急性心肌炎伴左室收缩功能障碍患者,比较暴发性心肌炎(FM)与非暴发性心肌炎(NFM)的预后。结果显示FM患者60天和7年心脏死亡或心脏移植率均显著高于NFM,且组织学亚型(巨细胞型)在FM中具有独立预后价值,提示需及时行心内膜心肌活检。
要点
- FM患者60天心脏死亡/移植率28.0% vs NFM 1.8%,7年47.7% vs 10.4%。
- FM中巨细胞心肌炎预后显著差于嗜酸性及淋巴细胞性心肌炎。
- 淋巴细胞性心肌炎亚组中FM预后仍显著劣于NFM。
核心结论
- FM患者短期和长期心脏死亡或心脏移植率均显著高于NFM患者。
- FM的组织学亚型具有独立预后价值,巨细胞心肌炎预后最差。
研究设计与样本
- 回顾性国际注册研究,纳入美国、欧洲、日本16家三级医院。
- 共220例经组织学证实的急性心肌炎(症状 onset <30天)伴左室收缩功能障碍患者,中位年龄42岁,46.3%女性。
- FM组165例,NFM组55例;主要终点为入院60天内及长期随访中心脏死亡或心脏移植。
主要发现
- FM vs NFM:60天心脏死亡/移植率28.0% vs 1.8%(p=0.0001)。
- FM vs NFM:7年心脏死亡/移植率47.7% vs 10.4%(p<0.0001)。
- Cox多因素分析显示组织学亚型是FM患者预后的独立影响因素,巨细胞心肌炎预后显著差于嗜酸性及淋巴细胞性心肌炎。
- 淋巴细胞性心肌炎成人亚组:FM vs NFM 60天主要终点19.5% vs 0%(p=0.005),7年41.4% vs 3.1%(p=0.0004)。
临床怎么用
- 对暴发性心肌炎患者应尽早行心内膜心肌活检以明确组织学亚型,指导预后判断。
- 巨细胞心肌炎亚型预后极差,需更积极监测和干预。
局限性
- 回顾性注册研究设计,可能存在选择偏倚。
- 样本量有限(共220例),亚组分析例数较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fulminant myocarditis (FM) is a form of acute myocarditis characterized by severe left ventricular systolic dysfunction requiring inotropes and/or mechanical circulatory support. A single-center study found that a patient with FM had better outcomes than those with acute nonfulminant myocarditis (NFM) presenting with left ventricular systolic dysfunction, but otherwise hemodynamically stable. This was recently challenged, so disagreement still exists. OBJECTIVES: This study sought to provide additional evidence on the outcome of FM and to ascertain whether patient stratification based on the main histologic subtypes can provide additional prognostic information. METHODS: A total of 220 patients (median age 42 years, 46.3% female) with histologically proven acute myocarditis (onset of symptoms <30 days) all presenting with left ventricular systolic dysfunction were included in a retrospective, international registry comprising 16 tertiary hospitals in the United States, Europe, and Japan. The main endpoint was the occurrence of cardiac death or heart transplantation within 60 days from admission and at long-term follow-up. RESULTS: Patients with FM (n = 165) had significantly higher rates of cardiac death and heart transplantation compared with those with NFM (n = 55), both at 60 days (28.0% vs. 1.8%, p = 0.0001) and at 7-year follow-up (47.7% vs. 10.4%, p < 0.0001). Using Cox multivariate analysis, the histologic subtype emerged as a further variable affecting the outcome in FM patients, with giant cell myocarditis having a significantly worse prognosis compared with eosinophilic and lymphocytic myocarditis. In a subanalysis including only adults with lymphocytic myocarditis, the main endpoints occurred more frequently in FM compared with in NFM both at 60 days (19.5% vs. 0%, p = 0.005) and at 7-year follow up (41.4% vs. 3.1%, p = 0.0004). CONCLUSIONS: This international registry confirms that patients with FM have higher rates of cardiac death and heart transplantation both in the short- and long-term compared with patients with NFM. Furthermore, we provide evidence that the histologic subtype of FM carries independent prognostic value, highlighting the need for timely endomyocardial biopsy in this condition.
引用
- Ammirati E, Veronese G, Brambatti M, et al. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2019. PMID: 31319912. doi:10.1016/j.jacc.2019.04.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。